hapabapa DocuSign (NASDAQ:DOCU) shares rose nearly 3% on Wednesday as investment firm Wedbush Securities upgraded the electronic-signature technology company, noting the negative catalysts have “played out” and downside from here is limited. Analyst Dan Ives moved his rating on DocuSign (DOCU) shares to neutral from underperform, noting that high-growth stocks have been hit hard in … Read more
Joe Raedle Carvana (NYSE:CVNA) shares slid again on Friday after announcing a new credit agreement with Ally Financial after Thursday’s market close. Per an 8-K filing detailing the agreement and its latest amendments, the restated credit agreement extends the duration of $2.2B credit line for a year and includes a $200M “participation” from Deutsche Bank’s … Read more
Article content BURNABY, British Columbia, Aug. 08, 2022 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that management will participate in virtual one-on-one investor meetings and a fireside chat presentation at the 13th Annual Wedbush PacGrow (Virtual) Healthcare Conference. Fireside Chat Details: Date: Wednesday, August 10, 2022 … Read more
JHVEPhoto/iStock Editorial via Getty Images Wayfair (NYSE:W) stock surged on Monday despite the expectation of a disappointing earnings report voiced by Wedbush analyst Seth Basham. “We remain sidelined on [Wayfair] (W) into 2Q22 earnings on Thursday, August 4,” he told clients. “While industry retail sales growth continued to increase 3% y/y in 2Q22, our checks, … Read more